New York, NY -- (SBWIRE) -- 12/17/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Astrotech Corp (NASDAQ:ASTC), Quiksilver, Inc (NYSE:ZQK)
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) the stock opened the session at $4.60 but then moved to $4.68. At that price, the stock showed a positive performance of 0.01%. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The Company’s product candidates include MM-398, MM-121, MM-111,
Will MACK Continue To Move Higher? Find Out Here
Astrotech Corp (NASDAQ:ASTC) opened the session at $1.82 and closed the session at $2.40. Traded with volume of 2.74 million shares in the prior session and the average volume of the stock remained 493,964.00 shares. Astrotech Corporation (Astrotech) is a commercial aerospace company. The Company's focused on providing world-class facilities and related support services necessary for the preparation of satellites and payloads; providing satellite and payload processing and integration service and support; designing and fabricating equipment and hardware for launch activities;
Is ASTC a Solid Investment at These Levels? Read This Report For Details
Quiksilver, Inc (NYSE:ZQK) opened the session at $8.40 and closed the session at $8.45. The stock showed a positive performance of 2.05% in previous trading session. The beta of the stock remained 2.74. Quiksilver, Inc. is a diversified company that designs, develops and distributes branded apparel, footwear, accessories and related products, catering to the casual, youth lifestyle associated with the sports of surfing, skateboarding and snowboarding. It markets products across three core brands:
Why Should Investors Buy ZQK After The Recent Gain? Just Go Here and Find Out
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)